- Investigator
- Larisa H Cavallari
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Genotype , 81 publications
- Pharmacogenetics , 65 publications
- Warfarin , 57 publications
- Anticoagulants , 49 publications
Research activity
Active clinical trials
- Investigator
- Larisa H Cavallari
- Status
- Accepting Candidates
This study will examine the effect of having genotype information on pain management and pain control for patients treated in family medicine clinics. This study will also examine physician-perceived usefulness of genotype information. Patients will…
- Investigator
- Larisa H Cavallari
- Status
- Accepting Candidates
- Ages
- 18 Years - 80 Years
- Sexes
- All
My publications
Filter publications
230 publications
2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.
JACC. Basic to translational science
•2024
CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.
Circulation
•2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Journal of the American Heart Association
2024
Decoding pharmacogenomic test interpretation and application to patient care
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
•2024
DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
The Journal of molecular diagnostics : JMD
•